Product image of Genotonorm Miniquick (Somatropin) supplied by GNH India

Genotonorm Miniquick

Active Ingredient:
Somatropin
Origin:
EU

Genotonorm Miniquick (Somatropin)

Genotonorm Miniquick is a somatropin injection used for growth hormone replacement therapy. This subcutaneous solution is manufactured by Pfizer S.L. and is suitable for various therapeutic uses.

Manufacturer / TM Owner

Pfizer S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Genotonorm Miniquick, containing somatropin, is primarily used for growth hormone replacement in individuals with deficiencies. It may also be prescribed for conditions where growth hormone levels are insufficient, such as in children with growth failure or adults with growth hormone deficiency. The medication is administered subcutaneously to support growth and development.

Side Effects

  • Common effects of Genotonorm Miniquick may include localized reactions at the injection site, such as redness or swelling. Some users might experience joint or muscle pain, headaches, or changes in blood sugar levels. These effects vary among individuals and are not exhaustive.

Precautions & Warnings

  • Genotonorm Miniquick should be handled with care, ensuring proper storage and administration as directed. It is important to follow medical guidance regarding dosage and frequency. Users should be aware of potential allergic reactions and seek medical advice if severe side effects occur.

Avoid Interactions

  • Genotonorm Miniquick may interact with other medications, including corticosteroids, insulin, and oral hypoglycemic agents. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain supplements may also affect its efficacy.

Frequently Asked Questions

Genotonorm Miniquick is used for growth hormone replacement therapy in individuals with deficiencies, supporting growth and development.

Genotonorm Miniquick is administered subcutaneously, typically through injection as directed by a healthcare provider.

Common side effects may include localized reactions at the injection site, joint or muscle pain, headaches, and changes in blood sugar levels.

Genotonorm Miniquick may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Genotonorm Miniquick is manufactured by Pfizer S.L. and is available in the EU.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT